Drug Development
-
AB SCIEX launches workhorse mass spectrometer for routine quantitation, screening
This system from AB SCIEX was developed based on feedback from scientists and application experts in analytical science that led to intelligently re-engineering the company’s existing API 4000.
Drug Development | 04 April 2012
-
Agilent Technologies introduces commercial hybrid supercritical fluid/UHPLC system
The 1260 Infinity Hybrid SFC/UHPLC system delivers LC-like sensitivity over the UHPLC power range.
Drug Development | 03 April 2012
-
BiotechCorp, Quintiles collaborate
Quintiles solidified the partnership with BiotechCorp, signifying interests in the areas of shared services central laboratory and biobank, clinical research graduate/internship training program, stem cell research and national vaccine hub.
Drug Development | 02 April 2012
-
Leukocare receives Frost & Sullivan’s biotechnology investment opportunity award
Leukocare has been awarded 2011’s Biotechnology Investment Opportunity Award by Frost & Sullivan.
Drug Development | 30 March 2012
-
Espicom predicts new novel approaches to the treatment of cancer will be launched by 2018
According to an Espicom report, Targeted Cancer D: The launch landscape to 2018,the global cancer market could be set for rapid growth in key sectors, driven by increasingly un-met clinical need and the introduction of new drugs which effectively target new pathways.
Drug Development | 29 March 2012
-
GEA Pharma appoints director of sales, business development for Latin America
GEA Pharma Systems has appointed Zósimo López Moreno as its director sales and business development for Latin America.
Drug Development | 22 March 2012
-
Agilent Technologies extends target-enrichment platform to desktop sequencers
Agilent Technologies expanded its SureSelect target-enrichment system with the HaloPlex target enrichment system for desktop sequencers.
Drug Development | 12 March 2012
-
Xceleron announces move to purpose-built laboratories
Xceleron announced that existing investors Albion Ventures and Solon Ventures have invested US$2.4 million to locate all of the company’s business in its custom-built facility in Germantown, MD.
Drug Development | 09 March 2012
-
High-throughput, high-salt measurements of electrophoretic mobility with Wyatt Technology’s Möbius
Wyatt Technology introduced its zeta potential instrument, the Möbius. The Möbius has been developed to automate the measurement of the mobility and the hydrodynamic radius of precious protein samples, increasing throughput without modifying the species.
Drug Development | 08 March 2012
-
Life Technologies partners with DaAn Gene
Life Technologies announced that it has signed an agreement with DaAn Gene, a Chinese company in molecular in-vitro diagnostics (IVD), to form Life Technologies DaAn Diagnostics, a joint venture diagnostics business in China. The move is expected to contribute to the early diagnosis of oncology, infectious diseases and genetic diseases. Financial terms of the deal were not disclosed.
Drug Development | 05 March 2012
